Document is current
Any future updates will be listed below
-
Authors
Bernstein, David I.
Cardin, Rhonda D.
Bravo, Fernando J.
Awasthi, Sita
Lu, Peiwen
Pullum, Derek A.
Dixon, David A.
Iwasaki, Akiko https://orcid.org/0000-0002-7824-9856
Friedman, Harvey M.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI054359)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (R01AI054359, R01AI054359, R01AI054359)
- License Information
-
More Information
Article History
Received: 4 March 2019
Accepted: 24 June 2019
First Online: 1 August 2019
Competing interests
: DIB is a consultant to Merck and Genocea regarding herpes vaccines. He also serves on a DSMB for Moderna. Harvey Friedman and Sita Awasthi are named on patents that describe the use of multiple subunit glycoprotein antigens for HSV vaccines. All other authors declare no competing interests.
